Allied academies invites
enumerous participants round the globe to attend a World Congress on Diabetes
and Nursing Management scheduled to be held on three consecutive
days starting from July 30-Aug 1, 2018
till 1st Aug, 2018 at Barcelona,
Spain. This Diabetes Congress 2018 is an event which brings together a unique and international mix of large
and medium companies /industries, leading universities and research
institutions making the conference a perfect platform to share experience,
faster collaborations across industry and academia, and evaluate emerging
technologies across the globe.
Allied Academies is organizing a World Congress on Diabetes, Complications and Nursing care management to prevent diabetes, brings together the Global leaders associated to Diabetes disorder, Doctors and relevant field professionals with Student researchers and related individuals to the Conference Tittle to present their research at this exclusive scientific event. Diabetes conference is hosting presentations from editors of journals, renowned and active investigators and decision makers in the field of Diabetic disorder and upcoming complications. Diabetes 2018 Organizing Committee Members also invites Young Researchers to submit abstracts reporting their research study and findings for Poster sessions.
- Academic Researcher
- Data Management Companies
- Medical Colleges
- Training Institute
- Diabetes Societies & Association
- Medical & Pharmacy Companies
- Software development Companies
- Business Entrepreneurs
- Manufacture medical devices & companies
Why to attend?
The World Congress subjective to “Diabetes and Nursing Management” will construct a global network of eminent speaker, subjective professionals, related individuals and academies to impart and receive knowledge on the title of conference and recent clinical approaches to fight diabetes as in concern with the theme by the World Health Organization- “Our Right to Healthy Future”.
Allied Academies unreservedly invites round the globe of the globe- Scientist, Subjective Professionals, Researchers, student delegates, Business executive, individuals linked to the subject of Diabetes by any perspective and encounters interest on the World Congress titled on “Diabetes and Nursing Management”. This World Congress is scheduled on 30th July,2018 with consecutive days ( 31st July & 1st Aug,2018) 1st Aug, 2018 is the end day of the World Congress in the city of Barcelona, Spain.
Diabetes mellitus is a group of metabolic disorders,characterized by elevated blood glucose levels. Diabetes occur if the body either does not produce enough insulin hormone, or because cells do not respond appropriately to the insulin produced (insulin resistance) or both. Borderline diabetes otherwise also known as pre diabetes, it’s a condition that develops before someone gets type 2 diabetes. It’s also known as impaired fasting glucose or glucose intolerance. Basically it is meant that blood sugar levels are higher than normal, but they are not quite enough to be known as diabetes. During pre diabetes phase, pancreas still produces enough insulin in response to ingested carbohydrates. The insulin is effective at removing the sugar from the bloodstream, though, so our blood sugar remains high. This condition is called insulin resistance. The A1C test is an indirect but reliable way of measuring the average blood sugar levels over the past 2 to 3 months. Pre diabetes is diagnosed when higher blood sugar levels are shown by an A1C Test result of between 5.7 and 6.4 percent. Fasting blood sugar levels in the range of 100- 125 mg/dL indicates pre diabetes, as do non fasting levels of 140-199 mg/Dl. This reading confirms the diagnosis of pre diabetes.
· Insulin resistance
· Impaired glucose tolerance
· Impaired fasting glucose
· Polycystic ovarian syndrome
Session 2: Significance of Genetics to Diabetes
Diabetes constitutes a significant public pathological state. Though substantial progress has been created in shaping the genetic science of metabolic syndrome risk for specific subtypes of polygenic disease (e.g., type 2 Diabetes of the young), the bulk of genetic risk of polygenic disease (for Type 1 and type 2) stay unresolved. This review focuses on the present information of the genetic basis of diabetes and its complications, specifically diabetic nephrosis (DN), recent advances in genetic science of Diabetes, Diabetes in ethnic teams, genetic manner interactions and understanding the genetic science of diabetes. Ultimately, identification of genes that contribute to risk (or protection) of diabetes and its complications can permit identification of patients United Nations agency have diabetes and area unit in danger and targeted treatment/interventional methods. Diabetic amyotrophic could be a disabling sickness that's distinct from alternative types of diabetic neuropathy.
The best studied is IDDM1, which contains the HLA genes that encode immune response proteins. Variations in HLA genes are an important genetic risk factor, but they alone do not account for the disease and other genes are involved. There are two other non-HLA genes which have been identified thus far. One of these non-HLA genes, IDDM2, is the insulin gene, and the other non-HLA gene maps close to CTLA4, which has a regulatory role in the immune response.
· High triglyceride and high cholesterol level
· History of gestational diabetes
· Body mass index
Session 3: Type 1 Diabetes Mellitus
Type 1 diabetes is an auto immune condition. It’s caused by the body attacking its own pancreas with antibodies. In people with type 1 diabetes, the damaged pancreas does not make insulin. This type of diabetes may be caused by genetic pre disposition. It could also be the result of faulty beta cells in the pancreas that normally produce insulin. A number of medical risk are associated with type 1 diabetes. Many of them stem from damage to the tiny blood vessels in eyes (called diabetic retinopathy), nerves (called diabetic neuropathy) and kidneys (called diabetic nephropathy). Even more serious is the increased risk of heart disease and stroke. Treatment for type 1 diabetes involves taking insulin, which needs to be injected through the skin into the fatty tissue below. A periodic test called A1C test estimates glucose levels in our blood over the previous three months.
· Maternal obesity
· Shape of glucose concentration curve
· Bio-markers of endothelial dysfunction.
· Respiratory infection
Session 4: Type 2 Diabetes Mellitus
The most common form of diabetes is type 2 diabetes, accounting for 95% of diabetes cause in adults. Type 2 diabetes used to be called adult-onset diabetes, but with the epidemic of obese and overweight kids, more teenagers are now developing type 2 diabetes. Type 2 diabetes also called non-insulin dependent diabetes. Type 2 diabetes can still cause major health complications, particularly in the smallest blood vessels in the bod that nourish the kidney, nerves and eyes. Type 2 diabetes also increases risk for heart disease and stroke. With type 2 diabetes the pancreas usually produces some insulin but either the insulin produced is not enough for the body’s need or the body’s cells are resistant to it. Insulin resistance happens primarily in fat, liver and muscle cell. There is no cure for diabetes but type 2 diabetes can be controlled by weight management, nutrition and exercise. An A1C test is a blood test that estimates average glucose level in blood.
· Kidney failure
· Limb amputation
· Hyperosmolar hyperglycemic state.
· Diabetic retinopathy- Blindness
Session 5: Gestational Diabetes
Gestational diabetes is high blood sugar that develops during pregnancy and usually disappears after giving birth. It can occur at any stage of pregnancy but it is more common in the second half. It occurs if a women’s body cannot produce enough insulin to meet the extra need in pregnancy. Any women can develop gestational diabetes during pregnancy but the increased risk if the pregnant women’s bod mass index is above 30, she previously had a baby who weighted above 4.5 kg or more, she had gestational diabetes during previous pregnancy. Some women may develop symptoms if their blood sugar level gets too high, hyper glycaemia such as increased thirst, need to pee more than usual, a dry mouth and tiredness. Gestational diabetes in a long term effect can lead to type 2 diabetes.
· Pre mature birth
· Pre- eclampsia
Session 6: Diabetic Cardiomyopathy
Diabetic cardiomyopathy is a disorder of the heart muscle in people with diabetes. It can lead to inability of heart to circulate blood through the body effectively, a state known as heart failure with pulmonary edema or peripheral edema. Most heart failure in people with diabetes results from coronary artery disease, and cardiac myopathy is only said to exist if there is no coronary artery disease. Diabetic cardiomyopathy is the long latent phase, during which the disease progresses but is completely asymptomatic. In most cases, diabetic cardiomyopathy is detected with concomitant hypertension or coronary artery disease. One of the earliest signs is mild left- ventricular diastolic dysfunction with little effect on ventricular filling. Also the diabetic patient may show subtle signs of diabetic cardiomyopathy related to decreased left ventricular complication or left ventricular hypertrophy or a combination of both.
· Ventricular dilation
· Enlargement of heart cells
· Prominent Interstitial fibrosis
· Decreased systolic function
Session 7: Diabetic Nephropathy
Diabetic nephropathy is the damage to kidney caused by diabetes. In many cases it can lead to kidney failure but not everyone with diabetes has kidney damage. The kidney has many tiny blood vessels that filter waste from blood. High blood sugar from diabetes can destroy these blood vessels. If the person has high blood pressure or high cholesterol then there’s a high risk. There is no symptom in the early stages therefore it is important to have regular urine test to find kidney damage early. If kidneys are less able to do their work then noticeable changes such as swelling in body, most often in feet and leg can be found. The problem is diagnosed using simple tests that check for a protein called albumin in the urine. Urine doesn’t usually contain protein but in early stages of kidney damage before one get any symptoms some protein may be found in urine, because kidney isn’t able to filter it out the way it should do. The main treatment is medicine to lower blood pressure and prevent the damage to kidney.
· ACE inhibitor
· Angiotensin II receptor blockers
Session 8: Diabetic Retinopathy
Diabetic Retinopathy is the most common form of diabetic eye disease. Retinopathy can affect all diabetes and becomes dangerous, increasing the risk of blindness if it is left untreated. Diabetic retinopathy occurs when changes in blood glucose levels cause changes in retinal blood vessels. In some cases, these vessels will swell up (macular edema) and leak fluid into the rear view of eye. In other cases, abnormal blood vessels will grow on the surface of the retina. Likewise many other condition diabetic retinopathy in early stages may have no significant symptoms and without pain. Macular edema can result from maculopathy and affect vision occurs if leaking fluid causes the macular to swell. New vessels on the retina can prompt bleeding, which can block vision in some cases. The symptoms of diabetic retinopathy in advance stage are sudden changes in vision, eye floaters and spots, double vision, eye pain. People are at high risk if affected with poor blood glucose control, protein in urine, high blood pressure, raised triglycerides in the blood.
· Background retinopathy
· Diabetic maculopathy
· Proliferative retinopathy
· Diabetic ophthalmology
· Rubeosis of iris
· Secondary glaucoma
· Complicated cataract
Endocrinology focuses primarily on the endocrine organs, or those organs that may cause a “hormone imbalance”. These organs include the pituitary, thyroid, adrenals, ovaries, testes and pancreas. This can be a complicated specialty. There are many glands and hormones in the body, each with their own jobs to do. It is a delicate chemical balance that keeps our bodies running smoothly with very little effort on our part. When the balance is upset, serious disease and conditions can develop. Endocrinologist can manage diabetes by prescribing insulin or medications, working on diet plans and keeping a check on blood glucose levels.
· Polycystic ovarian disease- Reproductive endocrinology
· Pituitary disorder
· Lipid disorder
· Congenital adrenal hyperplasia
Session 10: Diabetic Coma
Diabetic coma is a dread full diabetes complication that causes unconsciousness. Coma is relatively rare in diagnosed diabetes but it is important to know about the situation that increases the risk of coma. The main cause of coma occurring in people with diabetes are by low or very high blood glucose levels, Diabetic ketoacidosis is a dangerous state of having very high blood glucose levels (typically above 17 mmo/L) in combination with high ketone levels. Ketoacidosis is able to occur if the body runs out of insulin and is therefore a factor for people with type 1 diabetes to be aware of. Insulin can prevent ketone levels rising and this is the key reason why people with diabetes are advised never to miss their long term (basal) insulin injections. In type 2 diabetes, insulin levels in the body are usually present to stop ketone levels rising too high. However, at very high blood glucose levels (typically above 33 mmol/L) a dangerous condition called Hyperosmolar Hyperglycemic state (HHS) can develop.
· Severe hyper glycaemia
· Diabetic ketoacidosis
· Hyperglycemic hyperosmolar non ketotic coma
Session 11: Stem Cell Therapy for Diabetes Type 1 and Type 2
New treatments and advances in research are giving new approach to people suffering from diabetes type 1 and diabetes type 2. Mesenchymal stem cell therapy for diabetes type 1 and diabetes type 2 may help patients who don’t respond to typical drug treatment. The researchers are currently studying about adult adipose stem cell therapy as an alternative treatment to manage the complications associated with diabetes type 1 and type 2. The stem cells extracted from a patient may have the potential to reduce countless cells of the body, insulin producing cells included. In 2004, the university of Pittsburgh grew insulin producing beta cells by introducing two genes ‘cdk’ and ‘cyclin d’ via a virus. The researchers were able to deactivate the virus and also prevent stem cells from growing further. To cure type 1diabetes, stem cell replacement needs to be more than simply a case of swapping insulin-producing cells from a healthy pancreas with those destroyed by diabetes in a diabetic patient.
Session 12: Diabetes Dermatology
Diabetes can affect many part of our body including our skin. When diabetes affects the skin, it’s often a sign that our blood sugar levels are too high. This could mean that, undiagnosed diabetes or pre-diabetes, treatment for diabetes need to be adjusted. Some of the signs that are warnings to consult dermatologist are:
- Yellow, reddish or brown patches on skin
- Darker area of skin that feels like velvet
- Shin spots
Session 13: Diabetes
Type 1 diabetes is a chronic illness characterized by the body’s inability to produce insulin due to the autoimmune destruction of the beta cells in the pancreas. Most pediatric patients with diabetes have type 1 and a life time dependence on exogenous insulin.
Session 14: Diabetes and Colo-Rectal Cancer
Colorectal cancer is related with diabetes mellitus and both of these common conditions are managed together by a surgeon. Type II (non- insulin dependent) diabetes seems to increase colorectal cancer incidence. Colorectal cancer and diabetes are both common diseases in the Western World. Countries that have taken up a western lifestyle have also seen an increase in the incidence of both colorectal cancer and diabetes. Both case control and cohort studies have shown that type II diabetes increases the lifetime risk of colorectal cancer by up to three times the risk to the general population and that diabetes is independently associated with greater mortality in colorectal cancers. Diarrhea is one of the most common symptoms of colonic cancer. Diarrhea especially at night is a result of autonomic neuropathy and diabetic neuropathy is one of the most common symptomatic complications of diabetes. Patients with diabetes who have autonomic neuropathy are more likely to develop constipation. Diabetic patients are also more likely to develop feacal incontinence. Impotence and both urinary and faecal incontinence following rectal surgery is certainly technique dependent in addition to factors including diabetes, smoking, alcohol and other medications. Anastomotic leak is the largest risk of mortality following colorectal surgery and most surgeons agree that diabetes is a risk factor in rectal surgery.
· Bowel motility- Gastro paresis
· Colonoscopy and diabetes
· Anastomotic factors
Session 15: Chemotherapy Effects in Diabetes
Chemotherapy in diabetic patients is a complex challenge. Not only is the diabetic control an issue, but following resection patients is more prone to loose stool. A large randomized controlled trial showed that patients with diabetes and stage 2/3 disease were more likely to suffer severe diarrhea as a result of chemotherapy than patients without diabetes.1 Patients with diabetes are also more likely to suffer from cardiovascular disease, renal failure and neuropathy all of which can be exacerbated by chemotherapeutic agents.
· Loss of appetite
· Sick because of chemotherapy drugs
· Effect body’s ability to fight infection
Session 16: Diabetes: Nutrition/Diet Plan
Diabetes diet is eating the healthiest foods in moderate amount and sticky to regular meal times. Diabetes nutrition is a healthy eating plan that’s naturally rich in nutrients and low in fat and calories. Key elements are fruits, vegetables and whole grains. In fact, a diabetes diet plan is the best eating plan for most everyone
· Healthy carbohydrates
· Fiber rich food
· Heart healthy fish
· “Good” Fats
FOODS TO AVOID:
· Saturated fats
· Trans fats
The concept of 'new technologies' for type 1 diabetes and new discovery and advanced type 2 diabetes treatment has expanded in recent years at a rate that some might consider comparable to 'Moore’s Law', and the sheer number of new technologies entering into the type 1 diabetes marketplace is also growing at a remarkable rate. From the patient’s perspective, this is not only exciting but can lead to a sense of optimism. Technologies that today are growing commonplace (e.g. insulin pumps, rapid HbA1c monitoring, etc. come under new therapeutic mechanisms of diabetes. Indeed, it could be argued that the major advances in type 1 diabetes care made within the last quarter of a century have come from technology rather than biology. At the same time, not all new technologies succeed (e.g. the Glucowatch), regardless of their purported promise. Both type 1 diabetes patients and their healthcare providers will soon see a series of further advanced medical technologies used in hospital and new technologies and novel therapies in diabetes treatment whose basis is tied to the notion of improving the lives of those with the disease.
The aim of diabetes treatment is to keep, within reason, blood glucose levels as near to normal as possible. Training in self-management of diabetes forms an essential part of diabetes management. Treatment should be agreed on an individual basis and address medical, psychosocial and lifestyle issues.
A variety of different factors have a role to play in treating diabetes, but the importance of balanced, coordinated diabetes treatment for all diabetics cannot be underestimated
Regular and successful treatment decreases the risk of each patient developing diabetes complications.
· Bariatric surgery versus conventional therapy
· Challenges in the selection of innovation into Diabetes
· New therapeutic mechanisms for Diabetes
· Diabetic Medications and Insulin Pumps
· Low Carbohydrate and Ketogenic Diet
· New Insulin conveyance systems: Inhaled, transdermal and embedded devices
· Glucose sensors (invasive and non-invasive)
· Artificial Pancreas and Encapsulation
· Computational approach to chemical etiologies of Diabetes
Session 18: Nursing Management/Care for Diabetes
Nursing management of diabetes includes effective treatment to normalize blood glucose and decrease complications using insulin replacement, balanced diet and exercise. The nurse should stress the importance of complying with the prescribed treatment program. Management includes teaching patient’s needs, abilities and developmental stage. Stress the effect of blood glucose control on long-term health.
NURSING CARE PLAN:
- Risk for unstable Blood Glucose
- Deficient Knowledge consequences
- Risk for infection
- Risk for Disturbed Sensory Perception
- Risk for Ineffective Therapeutic Regimen Management
- Risk for injury
Market Analysis Report
Millions of people are suffering and also trying all kinds of diets, pills and treatment to clear their mental fog, to boost energy and to lose weight. Unfortunately, they will all fail unless they learn how to heal the underlying diabetes issue.
Number of people suffering from diabetes & continues to rise each year. As reported by the World Health Organization (WHO), on an average 1 out of every 13 people more specifically 20 million to 750 million cases are diagnosed globally with diabetes disease each year. There are more than 250 million cases of obesity globally. Around 60% of the populations effected with diabetes disorder are uncaring of the situation. Male & Female population is 5-6 times more likely to develop a Diabetes disorder.
Many International Conferences/meetings/symposium and workshops have been organized on different topics related to the risk factors of diabetes across the globe such as obesity conferences, weight loss conferences, Endocrine Conferences etc.
Allied Academies Cordially invites all the Academic Scientists, Leading Endocrinologists, Dibetologists, Pediatricians, Surgeons, General Physicians, Dieticians, Primary Health care specialists, talented young scientist, and student communities across the globe to attend European Diabetes Conference, where all the aspects of Diabetes Disorder and Treatment will be discussed under single roof. Diabetes 2018 will be an excellent amalgamation of academia and industry as it involves every aspects of empirical and conceptual thinking in exploring new dimensions in this field. It is open to all types of research methodologies both from academia and industry.
Diabetes 2018 is an International platform for presenting research about Diabetes significance, Disorders & Treatment, exchanging ideas about it and thus, contributes to the dissemination of knowledge in management of the disease for the benefit of the society.
Members Associated with Diabetes Research
The American Diabetes Association (ADA) serves as the professional for all the leading researchers and clinicians and also for the people in the field of Diabetes and provides a rich resource for the public and patients with Diabetes disease and Obesity. 1700 members from 43 different countries, working together in the organization of Researchers, Clinicians, Surgeons, and other Healthcare professionals to advance the care and treatment of patients with diabetes disease. Also to inspire, educate, apprise and train registered medical practitioners, dieticians, qualified nurses and other appropriately qualified paramedical personnel in the field of Diabetes various well known societies/associations are working across the world to professionally avoid and combat the lethal disease.
Societies Associated with Diabetes Research
FAND- Italian Association of Diabetes
Italian Association for the Defense of the Interest of Diabetics
Association of Diabetes
Association National Italian Diabetic Athletes
Italian Society of Diabetology
International Diabetes Federation-Italy
Primary Care Diabetes Society
Australian Diabetes Society
Emirates Diabetes Society
Immunology of Diabetes Society
American Association for the Study of Diabetes
International Association of the Diabetes and Pregnancy Study Groups
Diabetes Association of Nigeria
Association of Children’s Diabetes Clinicians
Canadian Diabetes Association
Barcelona- the metropolis nudged between the mountain scape and the sea was chosen as the city to organize this International Conference on “Diabetes and Nursing Management” due to its concoction of ultimate architecture, art, history and Catalonia culture. Bringing a vibrant blend of history and modernization, laying way for a foundation of inspiration, creativity for a dynamic and valuable scientific session as a Diabetes Conference.